Discover the most-read SMA stories of 2025, featuring updates on the gene therapy Zolgensma, next-generation treatments, and ...

Leuprorelin acetate, a medicine approved in the U.S. for prostate cancer, may slow the progression of SMA type SBMA, ...

This Christmas, columnist Ari Anderson gives thanks that some health complications he experienced post-surgery resolved on ...

Columnist Connie Chandler offers a message of courage and hope for those spending this season in a hospital bed.

A new review of studies reveals that incorporating SMA into newborn screening programs yields clinical improvements and ...

Disability life coaching is turning out to be just the balm columnist Brianna Albers needed to recall the importance of community in SMA.

Columnist Ari Anderson pays tribute to his mom, who excels at many roles, including advocate, manager, teacher, and caregiver ...

Sixteen years after her daughter's diagnosis of SMA type 1, guest columnist Cherie Ehlert is no longer counting the months, ...

Cherie Ehlert lives in Vancouver, British Columbia, Canada. She is a disability advocate and created “Charlie's Angels” to ...

Columnist Helen Baldwin finds the perfect gift for her granddaughter's birthday, one of the many unexpected blessings in her life.

Zolgensma improved motor function in SMA children with tracheostomies. No new safety risks were observed for SMA patients with tracheostomy who received Zolgensma. Many patients received Spinraza or ...